# Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy

> **NCT01904786** · PHASE1 · WITHDRAWN · sponsor: **St. Louis University**

## Conditions studied

- Newborn Hypoxic Ischemic Encephalopathy

## Interventions

- **DRUG:** Melatonin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01904786
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2017-12
- **Final completion:** 2018-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment of suitable candidates
- **Last updated:** 2015-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01904786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01904786, "Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01904786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*